LPS-Treated Podocytes Polarize Naive CD4⁺ T Cells into Th17 and Treg Cells

Figure 1

The expression of CD80, MHC II, and TLR4 mRNA in LPS-treated podocytes. PCL cells were cultured for 6 hours with or without 25 μg/ml LPS. CD80, MHC II, and TLR4 mRNA were examined and compared among the 0 h untreated, 6 h untreated, and 6 h LPS-treated groups. CD80 and MHC II were measured by flow cytometry while TLR4 mRNA by qRT-PCR. (a) Schematic diagram of this study. (b–d) The levels of CD80 and MHC II expressed in podocytes in the 0 h untreated group (b), 6 h untreated group (c), and 6 h LPS-treated group (d) were calculated, respectively. (e–h) Comparison of the CD80, MHC II, and TLR4 mRNA expressions in podocytes among groups. Data are shown as the . . /group. PCL: podocyte cell line; BMDCs: bone marrow-derived dendritic cells.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)